Taoka Chemical raised its full-year ordinary profit forecast for the current fiscal year from its previous forecast, indicating a 57.1% increase. Second-half ordinary profit is projected at ¥150 million.
Taoka Chemical announced that consolidated ordinary profit for the cumulative second quarter of the fiscal year ending March 2027 (April-September) fell sharply to ¥390 million, down 72.5% year on year.
At the same time, it raised its full-year ordinary profit forecast from the previous forecast of ¥350 million to ¥550 million, an upward revision of 57.1%, and expects the rate of decline in profit to narrow significantly.
Consolidated ordinary profit for July-September, the most recent three-month period, fell to ¥220 million, down 67.5% year on year, while the operating margin deteriorated from 7.3% to 2.6%.
For the second half, consolidated ordinary profit for October-March is calculated to fall to ¥150 million, down 76.5% year on year.